Dr. Leora Fox keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

HDSA Accepting Letters of Interest for 2020 Centers of Excellence Program

Posted on August 15, 2019

HDSA’s Centers of Excellence (COEs) provide multidisciplinary care services to families affected by Huntington’s disease, including neurology, psychology, genetic counseling,…

Read More

Participate in HDSA’s Survey About PGD-IVF

Posted on August 8, 2019

HDSA is committed to providing individuals and families impacted by HD with the resources they need to make informed choices….

Read More

PRECISION-HD2 Results from Wave Life Sciences Expected in Late 2019

Posted on August 1, 2019

Wave Life Sciences is conducting two early safety studies of huntingtin-lowering therapies, called PRECISION-HD1 and PRECISION-HD2. In a business update…

Read More

HD Legacy: Brain Donation for HD Research

Posted on July 25, 2019

To enable cutting-edge Huntington’s disease research, HDSA is collaborating with CHDI to support the donation of brain and other organs…

Read More

Gene Silencing Therapy for Amyloidosis Approved in the UK

Posted on July 17, 2019

Last week saw the approval of a genetic therapy for a rare disease called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). As…

Read More

The Blog Returns: 34th Annual HDSA Convention Research Recap

Posted on July 11, 2019

This week, Dr. Fox returns from maternity leave and resumes the HDSA research blog! The 34th Annual HDSA Convention in…

Read More


Posted on April 4, 2019

May is HD awareness month, and every day HDSA will be sharing family stories, celebrity PSAs, HD facts and much…

Read More

Roche/Genentech Amends GENERATION-HD1 Study

Posted on March 28, 2019

On Thursday, March 21st, Roche/Genentech released a Community Statement about changes to the GENERATION-HD1 study, the clinical trial testing huntingtin-lowering…

Read More

Interview with Roche Representatives

Posted on March 21, 2019

A few weeks ago we blogged about the Annual CHDI Huntington’s disease Therapeutics Conference in Palm Springs, California. This week,…

Read More

Gene Therapy 101

Posted on March 14, 2019

In addition to ongoing clinical trials of Roche/Genentech and Wave huntingtin-lowering therapies, a number of other companies are developing drugs…

Read More

Annual CHDI Huntington’s Disease Therapeutics Conference

Posted on March 7, 2019

This week in Palm Springs, California, CHDI Foundation hosted the 14th Annual HD Therapeutics Conference. This yearly conference draws academic…

Read More

Second Annual HD-COPE Meeting

Posted on February 28, 2019

The Huntington’s Disease Coalition for Patient Engagement (HD-COPE) met this week in New York City. HD-COPE unites organizations serving HD…

Read More

HDSA Research Webinar on DNA Repair Next Thursday, February 20th

Posted on February 14, 2019

Over the past 15-20 years we have learned that the CAG repeat mutation that causes HD is dynamic – the…

Read More

HDSA Expands Centers of Excellence Program to 47 Sites

Posted on February 7, 2019

HDSA Centers of Excellence provide world-class multidisciplinary care to families all over the United States. Professionals at these locations include…

Read More

First Patient Enrolled in Pivotal Huntingtin-Lowering Trial

Posted on January 31, 2019

This week, Ionis Pharmaceuticals issued a press release stating that the Phase 3 trial of the huntingtin-lowering therapy formerly known…

Read More

Two Announcements From Drug Companies

Posted on January 24, 2019

This week, we learned that the SIGNAL trial has completed recruitment for its Phase 2 study of VX15/2503 (pepinemab), a…

Read More

2018 Research Year In Review Webinar Available

Posted on January 17, 2019

If you weren’t able to join us for the 2018 HD Research Year-in-Review webinar or would like to have another…

Read More

American Society of Human Genetics Chooses Huntington’s Disease as Topic for 2019 Essay Contest

Posted on January 10, 2019

The American Society of Human Genetics (ASHG) is a nonprofit organization whose mission is to advance human genetics in science,…

Read More

2018 Research Year in Review Webinar

Posted on January 3, 2019

To complement our 2018 Research Report, George and Leora will be sharing this year’s HD research highlights in our 2018…

Read More

Roche/Genentech Announces Locations of GENERATION HD1 Drug Study

Posted on December 20, 2018

On Wednesday, December 19th, Roche/Genentech announced the US and Canadian locations for their upcoming study to test efficacy of the huntingtin-lowering…

Read More